Characteristics of Primary and acquired multidrug-resistant tuberculosis patients in West Java, Indonesia
Rattachement africain : id. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Objectives: The increasing incidence of primary multidrug-resistant tuberculosis (MDR-TB) creates a new burden in national tuberculosis (TB) control. Understanding the characteristics of primary MDR-TB aids in predicting its spread. This study aimed to determine the differences in characteristics of primary and acquired MDR-TB patients in a hospital setting in Indonesia. Methods: This is a retrospective cohort study of adult patients (aged >18 years) with pulmonary MDR-TB who received treatment at Hasan Sadikin General Hospital, West Java, Indonesia. Patients who finished MDR-TB treatment between 2020 and 2022 were included. Patients whose therapeutic outcomes could not be determined and those with incomplete data were excluded. Results: This study included 337 participants; 32% were primary MDR-TB and 68% were acquired MDR-TB. Findings showed a significant difference between primary and acquired MDR-TB by contact with a TB index case. Primary MDR-TB was 4.31 times higher in patients who had contact (prevalence odds ratio 4.31, 95% confidence interval 2.65-7.01). Other characteristics showed some differences but were not statistically significant. Conclusion: Contact with the TB index case was found to differ significantly between primary and acquired MDR-TB. The transmission-driven nature of drug-resistant TB underscores the urgent need to reposition contact investigation and preventive therapy as central pillars of the MDR-TB control strategy.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Characteristics of Primary and acquired multidrug-resistant tuberculosis patients in West Java, Indonesia
- Date Crossref
- 01/09/2026
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Dr. Hasan Sadikin General Hospital pays non établi dans la noticeÉtablissement de santé
-
Padjadjaran University pays non établi dans la noticeUniversité ou école supérieure
-
Faculty of Medicine Department of Internal Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Center for Translational Biomarker Research pays non établi dans la noticeInstitution
Dr. Hasan Sadikin General Hospital, Padjadjaran University et Department of Internal Medicine — Faculty of Medicine, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.